PATHOPHYSIOLOGY • CARDIOVASCULAR PATHOPHYSIOLOGY

Valve Stenosis vs. Regurgitation

Understanding how valvular dysfunction disrupts hemodynamics and drives compensatory cardiac remodeling.

Historical Context & Motivation

The recognition of valvular heart disease as a distinct clinical entity has a rich history that parallels the development of physical examination skills, cardiac imaging, and surgical intervention. Long before clinicians could visualize the heart's internal structures, astute physicians recognized that abnormal sounds—murmurs—heard through the chest wall corresponded to specific patterns of valvular dysfunction. These early observations laid the groundwork for distinguishing between two fundamentally different mechanical failures: a valve that fails to open adequately (stenosis) and a valve that fails to close completely (regurgitation). Understanding this distinction is foundational for all healthcare professionals because the hemodynamic consequences, compensatory mechanisms, clinical presentations, and treatment strategies differ markedly between these two categories.

1816
Invention of the Stethoscope
René Laënnec invents the stethoscope, enabling auscultation of cardiac murmurs and providing the first reliable means of detecting valvular disease at the bedside.
1898
Pathological–Auscultatory Correlation
Sir James Mackenzie and others correlate specific murmur characteristics—timing, location, and quality—with autopsy findings, establishing the clinical framework for differentiating stenosis from regurgitation.
1953
First Successful Open-Heart Valve Surgery
John Gibbon uses the first heart-lung machine in a clinical setting, and Charles Hufnagel implants a caged-ball prosthetic aortic valve, marking the dawn of surgical correction for valvular disease.
1976
Doppler Echocardiography Era
The advent of Doppler echocardiography allows noninvasive quantification of transvalvular gradients, valve areas, and regurgitant fractions, revolutionizing diagnosis and clinical decision-making.
2002
Transcatheter Valve Interventions
Alain Cribier performs the first transcatheter aortic valve replacement (TAVR) in a human, inaugurating a minimally invasive era for treating stenotic and, later, regurgitant valvular disease.

Despite remarkable advances in imaging and intervention, the core pathophysiological question remains the same: how does impaired valve function alter the pressure and volume relationships within the cardiac chambers, and how does the heart compensate over time? Answering this question requires a clear understanding of the mechanical differences between stenosis and regurgitation and their downstream hemodynamic consequences.

Core Principles & Definitions

Every cardiac valve serves a single mechanical purpose: to permit unidirectional blood flow and prevent retrograde movement. When this function is compromised, the pathology falls into one of two broad categories. Valve stenosis refers to the narrowing or stiffening of a valve orifice, which obstructs forward flow and forces the upstream chamber to generate higher pressures to push blood through the restricted opening. Valve regurgitation (also called insufficiency or incompetence) occurs when the valve leaflets fail to coapt properly during closure, allowing blood to leak backward into the chamber from which it was just ejected. These two mechanisms impose fundamentally different types of hemodynamic stress on the myocardium: stenosis creates a pressure overload, while regurgitation creates a volume overload.

1

Stenosis = Pressure Overload

A narrowed valve creates resistance to forward flow. The upstream chamber must generate higher systolic (or diastolic) pressure to maintain adequate cardiac output, leading to concentric hypertrophy of the myocardium.
2

Regurgitation = Volume Overload

An incompetent valve allows blood to flow backward, increasing the total volume the upstream chamber must handle each cycle. This leads to chamber dilation and eccentric hypertrophy as sarcomeres are added in series.
3

Concentric vs. Eccentric Hypertrophy

Pressure overload triggers parallel addition of sarcomeres (wall thickening without dilation), whereas volume overload triggers series addition of sarcomeres (chamber enlargement with proportional wall thickening).
4

Compensated vs. Decompensated Phase

Initially, remodeling maintains cardiac output (compensated). Over time, the myocardium fails to keep pace with the hemodynamic burden, leading to reduced ejection fraction and clinical heart failure (decompensated).
KEY TAKEAWAY
Think of a cardiac valve as a door in a busy hallway. Stenosis is like the door being stuck partially closed—people (blood) must push harder to squeeze through, and a crowd (high pressure) builds on the upstream side. Regurgitation is like the door swinging both ways instead of locking shut—people who already passed through keep flooding back, so the upstream room gets overcrowded (volume overloaded) even though the door opens fully.

Visual Explanation: Hemodynamic Consequences

Left panel: In aortic stenosis, the narrowed valve (yellow bar) creates resistance to ejection. The left ventricle thickens its walls (concentric hypertrophy) to generate the elevated pressures needed. Right panel: In mitral regurgitation, the incompetent valve allows a backward jet (red arrow) into the left atrium during systole. The ventricle dilates to accommodate the increased total stroke volume (eccentric hypertrophy).

The diagram above illustrates the two distinct patterns of myocardial remodeling that develop in response to valvular disease. In stenosis, the chronically elevated afterload forces the left ventricle to add sarcomeres in parallel, producing concentric hypertrophy—a thickened ventricular wall with a normal or even reduced cavity size. This increased wall thickness helps normalize wall stress according to the Law of Laplace, but it also impairs diastolic relaxation and increases myocardial oxygen demand. In contrast, regurgitation leads to eccentric hypertrophy—chamber dilation with a proportional increase in wall thickness that initially maintains the ratio of wall thickness to cavity radius. The Frank-Starling mechanism supports forward stroke volume early in the disease course, but progressive dilation eventually exceeds the heart's compensatory capacity, culminating in systolic dysfunction and heart failure.

Hemodynamic Mechanisms & Key Equations

Although valvular pathophysiology is primarily a clinical discipline, several quantitative relationships are essential for understanding the severity grading and hemodynamic impact of stenosis and regurgitation. These equations link measurable echocardiographic parameters to the mechanical burden placed on the heart and guide clinical decision-making regarding the timing of intervention.

GORLIN EQUATION (STENOSIS SEVERITY)
AVA = CO ÷ (SEP × HR) ÷ (44.3 × √ΔP)
AVA = aortic valve area (cm²); CO = cardiac output (mL/min); SEP = systolic ejection period (s); HR = heart rate (beats/min); ΔP = mean transvalvular pressure gradient (mmHg); 44.3 = empirical constant. The Gorlin equation estimates the effective orifice area of a stenotic valve from catheterization data, directly linking gradient and flow to valve area.
LAW OF LAPLACE (WALL STRESS)
σ = (P × r) ÷ (2 × h)
σ = wall stress; P = intraventricular pressure; r = cavity radius; h = wall thickness. In stenosis (↑P), concentric hypertrophy (↑h) normalizes σ. In regurgitation (↑r due to dilation), eccentric hypertrophy must increase h proportionally to maintain σ.
REGURGITANT FRACTION
RF = (RV ÷ TSV) × 100%
RF = regurgitant fraction (%); RV = regurgitant volume (mL); TSV = total stroke volume (mL) = forward stroke volume + regurgitant volume. RF quantifies the severity of regurgitation; mild <30%, moderate 30–49%, severe ≥50%.
🩺 Clinical Note
The continuity equation (A₁ × V₁ = A₂ × V₂) is the noninvasive echocardiographic workhorse for estimating valve area. By measuring the left ventricular outflow tract (LVOT) diameter and velocity-time integrals on both sides of the valve, clinicians can calculate the effective orifice area without catheterization.

Detailed Breakdown by Valve

While the stenosis-versus-regurgitation framework applies to all four cardiac valves, the clinical significance, etiology, and hemodynamic consequences differ depending on which valve is affected. Left-sided valve disease (aortic and mitral) is far more common and clinically impactful than right-sided disease (pulmonic and tricuspid) because the left heart operates at substantially higher pressures. The following diagram and table provide a comparative overview of the most clinically relevant presentations.

This diagram organizes the four cardiac valves by side of the heart, listing the most common etiologies for stenosis and regurgitation of each. The bottom spectrum bar shows severity grading criteria for aortic stenosis (by valve area and mean gradient) and mitral regurgitation (by regurgitant fraction).
Comparison of two of the most clinically significant valvular lesions
FeatureAortic Stenosis (AS)Mitral Regurgitation (MR)
Most Common EtiologyCalcific degeneration (elderly); bicuspid aortic valve (younger)Mitral valve prolapse; ischemic papillary muscle dysfunction
Type of OverloadPressure overload (↑ LV systolic pressure)Volume overload (↑ LV end-diastolic volume)
Remodeling PatternConcentric hypertrophy (↑ wall thickness, normal cavity)Eccentric hypertrophy (↑ cavity size, proportional wall)
Classic MurmurCrescendo-decrescendo systolic murmur; best at RUSB, radiates to carotidsHolosystolic (pansystolic) murmur; best at apex, radiates to axilla
Classic Triad / SymptomsSyncope, angina, heart failure (SAD triad)Dyspnea, fatigue, palpitations; pulmonary edema in acute MR

Worked Example: Assessing Valve Disease Severity

Consider a 72-year-old patient presenting with exertional dyspnea and syncope. Echocardiography reveals an aortic valve with thickened, calcified leaflets. The LVOT diameter is 2.0 cm, LVOT velocity-time integral (VTI) is 22 cm, and the aortic valve VTI is 88 cm. Separately, Doppler across the mitral valve shows a total stroke volume of 110 mL and a forward stroke volume of 65 mL. Let us grade both the aortic stenosis and the coexisting mitral regurgitation.

Grading Aortic Stenosis Using the Continuity Equation
1
Step 1 — Calculate LVOT AreaThe LVOT is assumed to be circular. Area = π × (d/2)² = π × (2.0/2)² = π × 1.0² = 3.14 cm².
LVOT area = 3.14 cm²
2
Step 2 — Apply Continuity EquationThe continuity equation states: AVA × AV VTI = LVOT Area × LVOT VTI. Solving for AVA: AVA = (LVOT Area × LVOT VTI) ÷ AV VTI = (3.14 × 22) ÷ 88.
AVA = 69.08 ÷ 88 = 0.78 cm²
3
Step 3 — Grade Aortic Stenosis SeverityAn AVA < 1.0 cm² meets the criterion for severe aortic stenosis. Combined with the patient's symptoms (syncope and dyspnea), this meets the guideline threshold for intervention—likely surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR).
Severe AS (AVA = 0.78 cm²) — symptomatic → indication for intervention
4
Step 4 — Calculate Regurgitant Volume and Fraction for MRRegurgitant volume (RV) = Total stroke volume − Forward stroke volume = 110 − 65 = 45 mL. Regurgitant fraction (RF) = (45 ÷ 110) × 100% = 40.9%.
RF = 40.9% → Moderate mitral regurgitation (30–49%)
5
Step 5 — Synthesize the Clinical PictureThis patient has severe, symptomatic aortic stenosis with coexisting moderate mitral regurgitation. The left ventricle is under both pressure overload (from AS) and volume overload (from MR), creating a mixed hemodynamic burden. Concentric hypertrophy from the stenosis may coexist with some degree of chamber dilation from the regurgitation. Management prioritizes the more severe lesion—the aortic stenosis—while monitoring the MR, which may improve after aortic valve replacement reduces afterload.
Mixed valvular disease: Severe AS + Moderate MR → Prioritize SAVR/TAVR

Stenosis vs. Regurgitation: Comparative Analysis

A clear side-by-side comparison of the pathophysiological mechanisms, clinical findings, and management principles for stenosis and regurgitation reinforces the key distinctions that guide clinical reasoning. The following table consolidates the most important differentiators, including the nature of the hemodynamic burden, the type of murmur generated, and the general approach to treatment.

Comprehensive comparison of stenosis and regurgitation across pathophysiological and clinical domains
ParameterStenosisRegurgitation
Valve DefectFails to open fully; restricted orifice areaFails to close fully; allows retrograde flow
Hemodynamic BurdenPressure overload (↑ afterload)Volume overload (↑ preload)
Myocardial ResponseConcentric hypertrophy (sarcomeres in parallel)Eccentric hypertrophy (sarcomeres in series)
Chamber GeometryThick walls, small/normal cavityDilated cavity, proportionally thickened walls
Diastolic FunctionImpaired early (↓ compliance, diastolic dysfunction)Preserved initially; impaired late in decompensation
Onset ToleranceGradual onset; well-tolerated for yearsChronic: tolerated; Acute: poorly tolerated, may cause pulmonary edema
Pulse PressureNarrow (pulsus parvus et tardus in AS)Wide (bounding pulse, Corrigan pulse in AR)
Definitive TreatmentValve replacement (SAVR, TAVR) or valvuloplastyValve repair (preferred) or replacement; MitraClip for MR
KEY TAKEAWAY
A useful mnemonic for remembering the remodeling patterns is to think of the heart muscle as a team of workers. In stenosis, the workers stand shoulder-to-shoulder (parallel sarcomere addition) to push harder against a stuck door—building a thicker wall. In regurgitation, the workers form a longer chain (series sarcomere addition) to pass more buckets of water (extra blood volume) down the line—stretching the room larger. Knowing which pattern predominates tells you the chamber geometry to expect on imaging and the type of heart failure that will eventually develop.

Connections to Advanced Cardiovascular Pathophysiology

The concepts of pressure overload and volume overload extend well beyond valvular disease and serve as unifying principles throughout cardiovascular pathophysiology. Systemic hypertension produces chronic pressure overload on the left ventricle, mimicking the hemodynamic effects of aortic stenosis and leading to similar concentric hypertrophy patterns. Conversely, conditions that increase circulating volume—such as chronic kidney disease, high-output states (severe anemia, thyrotoxicosis, arteriovenous fistulae), and large left-to-right intracardiac shunts—create volume overload analogous to valvular regurgitation. Understanding these parallels allows clinicians to apply the same pathophysiological reasoning across a wide spectrum of cardiovascular diseases.

Bridging valvular pathophysiology to broader cardiovascular concepts
ConceptValvular ContextAdvanced / Extended Application
Pressure OverloadAortic stenosis → LV concentric hypertrophySystemic HTN, hypertrophic cardiomyopathy (HCM), coarctation of the aorta
Volume OverloadMitral/aortic regurgitation → LV eccentric hypertrophyVSD, PDA, chronic anemia, dilated cardiomyopathy (DCM)
Mixed OverloadCombined AS + MR (worked example)HTN + CKD with fluid overload; multiple concurrent valve lesions
Neurohormonal ActivationRAAS and SNS activation in decompensated valve diseaseFoundation for understanding HFrEF vs. HFpEF pharmacotherapy (ACE-I, ARBs, β-blockers, ARNI)

As you advance in cardiovascular medicine, you will encounter the distinction between heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). Decompensated stenosis frequently evolves into HFpEF (the thick, stiff ventricle fails to relax), while decompensated regurgitation more commonly progresses to HFrEF (the dilated ventricle loses contractile efficiency). This mapping is not absolute, but it provides a powerful conceptual framework linking valvular disease to the broader phenotypes of heart failure that dominate modern cardiology.

Practice Problems

PROBLEM 1CONCEPTUAL
A patient with chronic aortic stenosis undergoes echocardiography revealing a thickened left ventricular wall (14 mm) with a normal end-diastolic cavity diameter. What type of myocardial remodeling does this represent, and what hemodynamic mechanism drives it? Would you expect the same remodeling pattern in a patient with chronic aortic regurgitation? Explain why or why not.
PROBLEM 2BASIC CALCULATION
An echocardiogram shows: LVOT diameter = 2.2 cm, LVOT VTI = 20 cm, aortic valve VTI = 80 cm. Using the continuity equation, calculate the aortic valve area (AVA) and classify the severity of aortic stenosis.
PROBLEM 3INTERMEDIATE
A patient with mitral regurgitation has a total stroke volume of 130 mL and a forward (effective) stroke volume of 70 mL. Calculate the regurgitant volume and regurgitant fraction. The patient's heart rate is 75 bpm. What is the effective cardiac output, and how does it compare to the total cardiac output? Discuss the clinical significance of this discrepancy.
PROBLEM 4APPLIED
A 65-year-old patient with known chronic mitral regurgitation presents to the emergency department with sudden-onset severe dyspnea and pulmonary edema following a myocardial infarction. An echocardiogram shows a flail mitral valve leaflet with a ruptured papillary muscle, and the left atrium is not dilated. Explain why acute mitral regurgitation is hemodynamically more dangerous than chronic MR of similar severity, referencing the concepts of chamber compliance and compensatory remodeling.
PROBLEM 5CRITICAL THINKING
A patient has both moderate aortic stenosis (AVA 1.3 cm², mean gradient 25 mmHg) and moderate aortic regurgitation. Discuss how these two lesions interact hemodynamically. Specifically, address: (a) why the mean gradient may underestimate the true severity of the stenosis in this scenario, (b) what the expected LV remodeling pattern would be, and (c) what challenges this mixed lesion poses for determining the optimal timing of surgical intervention.

Lesson Summary

Valvular heart disease presents in two fundamental mechanical patterns. Stenosis occurs when a valve fails to open adequately, creating resistance to forward flow and imposing pressure overload on the upstream chamber. The myocardium compensates with concentric hypertrophy—parallel sarcomere addition that thickens the ventricular wall to normalize wall stress via the Law of Laplace. Regurgitation occurs when a valve fails to close completely, allowing backward flow and creating volume overload. The compensatory response is eccentric hypertrophy—series sarcomere addition that dilates the chamber to accommodate the extra volume.

Severity is graded using echocardiographic parameters including valve area (via the continuity equation or Gorlin equation for stenosis) and regurgitant fraction (for regurgitation). Both lesion types progress through a compensated phase (maintained cardiac output) and eventually a decompensated phase (heart failure). Acute regurgitation is particularly dangerous because the chambers have no time to remodel. Definitive treatment for severe stenosis is valve replacement (SAVR or TAVR), while regurgitation may be managed with valve repair when feasible. These principles of pressure versus volume overload extend broadly to hypertension, shunt lesions, and cardiomyopathy, making them foundational concepts in cardiovascular medicine.

Varsity Tutors • Pathophysiology • Valve Stenosis vs. Regurgitation